Ken Duncan > 강연자 & 자료

본문 바로가기

파이낸셜뉴스 부산파이낸셜뉴스 가이드포스트 파이낸셜뉴스재팬 fnMICE

강연자 & 자료

Ken Duncan

페이지 정보


Ken Duncan

Deputy Director, Discovery & Translational Sciences, Bill & Melinda Gates Foundation


Ken Duncan is Deputy Director of Discovery & Translational Sciences within the Global Health Program of the Bill & Melinda Gates Foundation. He leads the foundation’s efforts in drug discovery across therapeutic areas currently including TB, malaria, antivirals and contraception. He recently coordinated the drug discovery response to COVID-19 then developed and is implementing a strategy for pandemic preparedness, working together with other funding agencies, to identify safe, effective agents that can be deployed in low-resource settings. He established the TB Drug Accelerator, a new model of public-private collaboration, which aims to discover drug candidates that will contribute to a short-acting TB therapy. He played a major role in launching the Global Health Drug Discovery Institute in Beijing, China. He serves on the Selection Committee of the Global Health Innovative Technology Fund in Japan. Before joining the foundation in 2007, he spent 16 years in the pharmaceutical industry, most recently as Director, Diseases of the Developing World at GlaxoSmithKline.  During that time, he helped establish the Global Alliance for TB Drug Development and served on its Scientific Advisory Committee for six years. Dr. Duncan obtained a BSc in Molecular Biology from the University of Edinburgh and a PhD from the University of Glasgow, and completed Postdoctoral Research Fellowships at the University of Glasgow, Massachusetts Institute of Technology and Harvard Medical School.



서울특별시 서초구 강남대로 315, 파이낸셜뉴스빌딩 9층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail :
Copyright ⓒ파이낸셜뉴스. All rights reserved.